SCYNEXIS Inc at Needham Healthcare Conference Transcript
Good afternoon, everyone. This is Alan Carr, a biotech research analyst at Needham & Company. And welcome to the 19th Annual Needham Healthcare Conference, also our first virtual healthcare conference. Today we have from Scynexis Marco Taglietti, CEO, and Eric Francois, CFO. I'll hand it over to them to walk through the Scynexis presentation.
Thank you very much, Alan, for the introduction and many thanks to everyone joining our presentation. To start, so my name, I'm Marco Taglietti, I am the CEO and President of Scynexis. I am a physician, I am an infectious disease specialist by training. Before I start, my general counsel always reminds me to let you know that all the statements we will be making are forward-looking.
Let me begin actually talking about something which is on everyone's mind right now and this is the COVID-19 pandemic. These are truly unprecedented times. Actually as Alan was saying, this is the first time we have I think a virtual
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
